PeptideStack
5.2kquestions
20kanswers
220users

How should a twenty-person split be structured so a later dispute is resolvable?

Asked 3 Apr 2024Modified 2.3 years agoViewed 7.5k times
5

I am comparing three suppliers on documentation rather than on price.

I am trying to do this correctly the first time rather than learn it by getting it wrong.

I have already made one mistake here that cost me a vial, so I am being deliberately careful.

What is the correct sequence, and where is the step that people usually skip?

group-buy
group-buy

Pooled purchasing: how the economics work, what trust structure a pool needs, splitting a single tested lot, and the failure modes when the…

41 questionspayment-privacy
payment-privacy

Payment mechanics and their privacy properties: why suppliers ask for stablecoin transfers, what an on-chain transfer reveals, confirmation…

31 questionsvendor-vetting
vendor-vetting

Evaluating a supplier on evidence rather than reputation: testing history across batches, whether certificates are batch-specific, how failures…

436 questions
shareeditfollowflag
LD
askedloss_on_drying47k1383 Apr 2024
This is the first explanation of that which has actually made sense to me. – jana_horakova 9 months ago
8Note that the label instructions differ between agents on precisely this point. – Dr_Bram_Verhoeven 7 months ago
add a comment

No answers yet

This question has not been answered. It has been viewed 7.5k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.